2X-121

· Allarity Therapeutics

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for 2X-121, covering 2025-01-23 to 2025-08-28. Get the full timeline:

Most recent: Clinical Trial Update: Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian Cancer [Phase 2]